These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 17229909

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
    Hutchison CA, Plant T, Drayson M, Cockwell P, Kountouri M, Basnayake K, Harding S, Bradwell AR, Mead G.
    BMC Nephrol; 2008 Sep 22; 9():11. PubMed ID: 18808676
    [Abstract] [Full Text] [Related]

  • 4. Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.
    Hutchison CA, Heyne N, Airia P, Schindler R, Zickler D, Cook M, Cockwell P, Grima D.
    Nephrol Dial Transplant; 2012 Oct 22; 27(10):3823-8. PubMed ID: 22273664
    [Abstract] [Full Text] [Related]

  • 5. Serum free-light chain removal by high cutoff hemodialysis: optimizing removal and supportive care.
    Hutchison CA, Harding S, Mead G, Goehl H, Storr M, Bradwell A, Cockwell P.
    Artif Organs; 2008 Dec 22; 32(12):910-7. PubMed ID: 19133018
    [Abstract] [Full Text] [Related]

  • 6. Extracorporeal treatment of cast nephropathy.
    Gakhar B, Kobrin S, Berns JS.
    Semin Dial; 2011 Dec 22; 24(1):9-11. PubMed ID: 21324000
    [Abstract] [Full Text] [Related]

  • 7. Online high-efficiency haemodiafiltration achieves higher serum free light chain removal than high-flux haemodialysis in multiple myeloma patients: preliminary quantitative study.
    Granger Vallée A, Chenine L, Leray-Moragues H, Patrier L, Cognot C, Cartron G, Cristol JP, Canaud B.
    Nephrol Dial Transplant; 2011 Nov 22; 26(11):3627-33. PubMed ID: 21508098
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Management options for cast nephropathy in multiple myeloma.
    Cockwell P, Hutchison CA.
    Curr Opin Nephrol Hypertens; 2010 Nov 22; 19(6):550-5. PubMed ID: 20827195
    [Abstract] [Full Text] [Related]

  • 10. Impact of free light chain hemodialysis in myeloma cast nephropathy: a case-control study.
    Peters NO, Laurain E, Cridlig J, Hulin C, Cao-Huu T, Frimat L.
    Hemodial Int; 2011 Oct 22; 15(4):538-45. PubMed ID: 22111823
    [Abstract] [Full Text] [Related]

  • 11. Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma.
    Martín-Reyes G, Toledo-Rojas R, Torres-de Rueda Á, Sola-Moyano E, Blanca-Martos L, Fuentes-Sánchez L, Martínez-Esteban MD, Díez-de los Ríos MJ, Bailén-García A, González-Molina M, García-González I.
    Nefrologia; 2012 Oct 22; 32(1):35-43. PubMed ID: 22294003
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum free light chains for monitoring multiple myeloma.
    Mead GP, Carr-Smith HD, Drayson MT, Morgan GJ, Child JA, Bradwell AR.
    Br J Haematol; 2004 Aug 22; 126(3):348-54. PubMed ID: 15257706
    [Abstract] [Full Text] [Related]

  • 15. Recovery of kidney function following delayed use of Theralite™ dialyzer in a patient with myeloma cast nephropathy.
    Dahal K, Shastri S, Narayanasami U, Bijol V, Rider K, Strom JA, Jaber BL.
    Clin Nephrol; 2013 Apr 22; 79(4):318-22. PubMed ID: 22541683
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aggregated serum free light chains may prevent adequate removal by high cut-off haemodialysis.
    Harding S, Provot F, Beuscart JB, Cook M, Bradwell AR, Stringer S, White D, Cockwell P, Hutchison CA.
    Nephrol Dial Transplant; 2011 Apr 22; 26(4):1438. PubMed ID: 21406545
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis.
    Hutchison CA, Bradwell AR, Cook M, Basnayake K, Basu S, Harding S, Hattersley J, Evans ND, Chappel MJ, Sampson P, Foggensteiner L, Adu D, Cockwell P.
    Clin J Am Soc Nephrol; 2009 Apr 22; 4(4):745-54. PubMed ID: 19339414
    [Abstract] [Full Text] [Related]

  • 20. The use of medium cutoff dialyzers in patients with multiple myeloma and acute kidney injury requiring hemodialysis: A systematic review.
    Koniman R, Teo SH, Kaushik M, Nagarajan C, Tan MSY, Tan HK, Ramirez MEG, Lim CC, S.I.N:G.A.P.O.R.E Initiative (Science In Nephrology: Growth And Progress Of Research & Education).
    Semin Dial; 2023 Jan 22; 36(1):12-17. PubMed ID: 35840146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.